The pandemic of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has been posing great threats to the world in many aspects. Effective therapeutic and …

A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions are surrounded by
a lipid bilayer from which spike (S) protein trimers protrude. Heavily glycosylated S trimers …

Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain
(RBD) of the trimeric spike. Here, we characterized polyclonal immunoglobulin Gs (IgGs) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in the
multisystem inflammatory syndrome in children (MIS-C). The clinical presentation of MIS-C …

Objective This study aimed to conduct a systematic review of the current literature to
determine estimates of vertical transmission of coronavirus disease 2019 based on early …

SARS coronavirus 2 (SARS-CoV-2) isolates encoding a D614G mutation in the viral spike
(S) protein predominate over time in locales where it is found, implying that this change …

An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity is a major
concern in coronavirus disease 2019 (COVID-19) prevention and economic reopening …

The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and
contextualize epidemiological, demographic and clinical findings for COVID-19 cases during …